• ##navigation.register##
  • ##navigation.login##
    • en
    • uz
    • ru
  • en
  • uz
  • ru
##navigation.register## ##navigation.login##
  • Joriy
  • ##navigation.archives##
    • ##about.aboutContext##
    • ##about.submissions##
    • ##common.editorialMasthead##
    • ##manager.setup.privacyStatement##
    • ##about.contact##
Joriy ##navigation.archives##
##about.aboutContext## ##about.submissions## ##common.editorialMasthead## ##manager.setup.privacyStatement## ##about.contact##
  1. ##common.homepageNavigationLabel##
  2. ##common.search##

##common.search##

##search.advancedFilters##
##search.dateFrom##
##search.dateTo##

##search.searchResults##

##search.searchResults.foundSingle##
  • REGIONAL DIFFERENCES IN THE HEPATITIS B AND C CARE CASCADE IN THE REPUBLIC OF KARAKALPAKSTAN: RESULTS OF MASS SCREENING, 2023–2025

    Muratbaeva A.P., Tadjiev B.M.

    Objective: to assess regional differences in the prevalence of viral hepatitis B and C, and in the structure of the HCV care cascade, using data from the mass population screening program in the Republic of Karakalpakstan in 2023–2025. Materials and methods: a retrospective analysis was performed of mass screening data for 110,578 people in 17 administrative districts of the Republic of Karakalpakstan (May 2023 – July 2025). Pearson's χ² test with Cramér's V (Jamovi, p<0.05) was used to assess the association between district/type of facility and passage through the stages of the care cascade. Results: a positive anti-HCV result was found in 3,451 people (3.1%) and a positive HBsAg result in 2,159 people (2.0%). The highest concentration of anti-HCV was observed in Turtkul district (9.0%). Referral for consultation after confirmation of viremia depended significantly on district and type of facility (χ²=198.5; p<0.001; Cramér's V=0.31); the largest patient losses were in the Turtkul, Kanlykul and Shumanay districts. Only 13.2% of initially positive patients were tested for SVR. Conclusion. The mass screening program in the Republic of Karakalpakstan in 2023–2025 (n=110,578) revealed regional differences both in the prevalence of viral hepatitis B and C and in passage through the stages of the HCV care cascade. The results support the need to decentralize certain stages of medical care for patients with HCV in order to reach the 2030 elimination goals.

    86-92
    16-11-2026
    Davomini o‘qing
##navigation.items##

Ma'lumot

  • ##navigation.infoForReaders##
  • Mualliflar uchun
  • Kutubxonachilar uchun

So'nggi nashrlar

  • Atom logotipi
  • RSS2 logotipi
  • RSS1 logotipi
TNMU Publishing

Biz tibbiyotning rivojlanishini tezlashtirish va jamiyat salomatligini yaxshilash uchun tadqiqotchilar, bilim va texnologiyalarni birlashtiramiz.

 

Navigatsiya

Bosh sahifa
Jurnallar
Konferensiyalar
Mualliflar
Taqrizchilar
Nashriyot xizmatlari

Madad

Ijodkor qoidalari
Nashr axloqi
Biz haqimizda
Savol-javob
Qayta aloqa

Kontaktlar

 
O‘zbekiston, Toshkent,,
Olmazor tumani, Shifokorlar ko‘chasi, 21-uy
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
##user.login##
Central Asian Journal of Medicine
##user.login##
* ##common.required##
* ##common.required##
##user.login.forgotPassword##
##user.login.rememberUsernameAndPassword##
##user.login.registerNewAccount##